American International Group, Inc. Rapt Therapeutics, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 14,556 shares of RAPT stock, worth $40,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,556

Previous 14,681 0.85%

Holding current value

$40,611

Previous $364,000 64.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.87 - $26.45 $858 - $3,306	-125 Reduced 0.85%	14,556 $130,000
Q4 2023 Feb 13, 2024	SELL	$11.28 - $25.46 $676 - $1,527	-60 Reduced 0.41%	14,681 $364,000
Q3 2023 Nov 13, 2023	BUY	$16.34 - $24.66 $8,578 - $12,946	525 Added 3.69%	14,741 $244,000
Q2 2023 Aug 04, 2023	SELL	$16.06 - $21.61 $2,842 - $3,824	-177 Reduced 1.23%	14,216 $265,000
Q1 2023 May 12, 2023	BUY	$17.19 - $30.8 $33,709 - $60,398	1,961 Added 15.77%	14,393 $264,000

Q4 2022 Feb 10, 2023	BUY	$16.28 - $24.6 $1,432 - $2,164	88 Added 0.71%	12,432 $246,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $3,143 - $5,330	175 Added 1.44%	12,344 $297,000
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $16,303 - $37,484	1,589 Added 15.02%	12,169 $222,000
Q1 2022 May 13, 2022	SELL	$17.02 - $40.22 $12,662 - $29,923	-744 Reduced 6.57%	10,580 $233,000
Q4 2021 Feb 11, 2022	SELL	$29.5 - $39.5 $9,971 - $13,351	-338 Reduced 2.9%	11,324 $416,000
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $47,537 - $62,836	1,592 Added 15.81%	11,662 $362,000
Q2 2021 Aug 13, 2021	BUY	$17.99 - $40.02 $66,113 - $147,073	3,675 Added 57.47%	10,070 $320,000
Q1 2021 May 07, 2021	BUY	$16.0 - $24.46 $272 - $415	17 Added 0.27%	6,395 $142,000
Q4 2020 Feb 12, 2021	SELL	$15.89 - $40.87 $2,891 - $7,438	-182 Reduced 2.77%	6,378 $126,000
Q3 2020 Nov 04, 2020	SELL	$21.6 - $37.5 $3,240 - $5,625	-150 Reduced 2.24%	6,560 $211,000
Q2 2020 Aug 12, 2020	BUY	$14.16 - $32.85 $80,117 - $185,865	5,658 Added 537.83%	6,710 $195,000
Q1 2020 May 04, 2020	BUY	$11.86 - $48.86 $925 - $3,811	78 Added 8.01%	1,052 $22,000
Q4 2019 Feb 05, 2020	BUY	$12.3 - $30.78 $11,980 - $29,979	974 New	974 $27,000

Others Institutions Holding RAPT

# of Institutions

147

Shares Held

29.2M

Call Options Held

709K

Put Options Held

1.06M

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $82.7M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Rapt Therapeutics, Inc. Transaction History